Covid statistics in the world

Coronavirus update

The bulk of this blog is reprinted with permission from the Orthomolecular Medicine News Service. If you missed my earlier blog on Coronavirus, you can access it here.

I’m going to urge you to share this information. Unfortunately, holistic articles are now being unfavored by Google, Facebook, YouTube and other internet search engines. It’s up to us as a grassroots effort to spread this important content. Thank you! And a special thanks to Donna for sharing it with me!

The following articles contain multiple scientific references to back up the claims. The protocol is easy and inexpensive.

I listened to much of the President’s Coronavirus task force broadcast last night, and it looks inevitable that we will get more Coronavirus here in the US. That doesn’t mean to worry, though! Read my earlier blog to make yourself resistant and follow the protocols below. Remember, the flu is more fatal than Coronavirus and the protocols I wrote about in the earlier blog have kept my clients either flu-free or recovering well over my 30 year career. Also remember that the media’s purpose is to rile people up so they will tune in more often. Stay informed, but don’t panic.

This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.

FOR IMMEDIATE RELEASE

Orthomolecular Medicine News Service, Jan 26, 2020

Vitamin C Protects Against Coronavirus

by Andrew W. Saul, Editor

(OMNS January 26, 2020) The coronavirus pandemic can be dramatically slowed, or stopped, with the immediate widespread use of high doses of vitamin C. Physicians have demonstrated the powerful antiviral action of vitamin C for decades. There has been a lack of media coverage of this effective and successful approach against viruses in general, and coronavirus in particular.

It is very important to maximize the body’s anti-oxidative capacity and natural immunity to prevent and minimize symptoms when a virus attacks the human body. The host environment is crucial. Preventing is obviously easier than treating severe illness. But treat serious illness seriously. Do not hesitate to seek medical attention. It is not an either-or choice. Vitamin C can be used right along with medicines when they are indicated.

“I have not seen any flu yet that was not cured or markedly ameliorated by massive doses of vitamin C.” 

(Robert F. Cathcart, MD)

The physicians of the Orthomolecular Medicine News Service and the International Society for Orthomolecular Medicine urge a nutrient-based method to prevent or minimize symptoms for future viral infection. The following inexpensive supplemental levels are recommended for adults; for children reduce these in proportion to body weight:

Vitamin C: 3,000 milligrams (or more) daily, in divided doses.

Vitamin D3: 2,000 International Units daily. (Start with 5,000 IU/day for two weeks, then reduce to 2,000)

Magnesium: 400 mg daily (in citrate, malate, chelate, or chloride form)

Zinc: 20 mg daily

Selenium: 100 mcg (micrograms) daily

Vitamin C [1], Vitamin D [2], magnesium [3], zinc [4], and selenium [5] have been shown to strengthen the immune system against viruses.

The basis for using high doses of vitamin C to prevent and combat virus-caused illness may be traced back to vitamin C’s early success against polio, first reported in the late 1940s.[6] Many people are unaware, even surprised, to learn this. Further clinical evidence built up over the decades, leading to an anti-virus protocol published in 1980.[7]

It is important to remember that preventing and treating respiratory infections with large amounts of vitamin C is well established . Those who believe that vitamin C generally has merit, but massive doses are ineffective or somehow harmful, will do well to read the original papers for themselves. To dismiss the work of these doctors simply because they had success so long ago sidesteps a more important question: Why has the benefit of their clinical experience not been presented to the public by responsible governmental authorities, especially in the face of a viral pandemic.

References:

1. Vitamin C:

Case HS (2018) Vitamin C questions answered. Orthomolecular Medicine News Service,http://orthomolecular.org/resources/omns/v14n12.shtml.

Gonzalez MJ, Berdiel MJ, Duconge J (2018) High dose vitamin C and influenza: A case report. J Orthomol Med. June, 2018, 33(3). https://isom.ca/article/high-dose-vitamin-c-influenza-case-report.

Gorton HC, Jarvis K (1999) The effectiveness of vitamin C in preventing and relieving the symptoms of virus-induced respiratory infections. J Manip Physiol Ther, 22:8, 530-533. https://www.ncbi.nlm.nih.gov/pubmed/10543583

Hemilä H (2017) Vitamin C and infections. Nutrients. 9(4). pii:E339. https://www.ncbi.nlm.nih.gov/pubmed/28353648.

Hickey S, Saul AW (2015) Vitamin C: The real story. Basic Health Pub. ISBN-13: 978-1591202233.

Levy TE (2014) The clinical impact of vitamin C. Orthomolecular Medicine News Service,http://orthomolecular.org/resources/omns/v10n14.shtml

OMNS (2007) Vitamin C: a highly effective treatment for colds.http://orthomolecular.org/resources/omns/v03n05.shtml.

OMNS (2009) Vitamin C as an antiviral http://orthomolecular.org/resources/omns/v05n09.shtml.

Taylor T (2017) Vitamin C material: where to start, what to watch. OMNS,http://www.orthomolecular.org/resources/omns/v13n20.shtml.

Yejin Kim, Hyemin Kim, Seyeon Bae et al. (2013) Vitamin C is an essential factor on the anti-viral immune responses through the production of interferon-α/β at the initial stage of influenza A virus (H3N2) infection. Immune Netw. 13:70-74. https://www.ncbi.nlm.nih.gov/pubmed/23700397.

2. Vitamin D:

Cannell JJ, Vieth R, Umhau JC et al. (2006) Epidemic influenza and vitamin D. Epidemiol Infect. 134:1129-1140.https://www.ncbi.nlm.nih.gov/pubmed/16959053.

Cannell JJ, Zasloff M, Garland CF et al. (2008) On the epidemiology of influenza. Virol J. 5:29.https://www.ncbi.nlm.nih.gov/pubmed/16959053.

Ginde AA, Mansbach JM, Camargo CA Jr. (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National

Health and Nutrition Examination Survey. Arch Intern Med. 169:384-390.https://www.ncbi.nlm.nih.gov/pubmed/19237723.

Martineau AR, Jolliffe DA, Hooper RL et al. (2017) Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 356:i6583.https://www.ncbi.nlm.nih.gov/pubmed/28202713.

Urashima M, Segawa T, Okazaki M et al. (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 91:1255-60. https://www.ncbi.nlm.nih.gov/pubmed/20219962.

von Essen MR, Kongsbak M, Schjerling P et al. (2010) Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 11:344-349. https://www.ncbi.nlm.nih.gov/pubmed/20208539.

3. Magnesium:

Dean C (2017) Magnesium. OMNS, http://www.orthomolecular.org/resources/omns/v13n22.shtml

Dean C. (2017) The Magnesium Miracle. 2nd Ed., Ballantine Books. ISBN-13: 978-0399594441.

Levy TE (2019) Magnesium: Reversing Disease. Medfox Pub. ISBN-13: 978-0998312408

4. Zinc:

Fraker PJ, King LE, Laakko T, Vollmer TL. (2000) The dynamic link between the integrity of the immune system and zinc status. J Nutr. 130:1399S-406S. https://www.ncbi.nlm.nih.gov/pubmed/10801951.

Liu MJ, Bao S, Gálvez-Peralta M, et al. (2013) ZIP8 regulates host defense through zinc-mediated inhibition of NF-кB. Cell Rep. 3:386-400. https://www.ncbi.nlm.nih.gov/pubmed/23403290.

Mocchegiani E, Muzzioli M. (2000) Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections. J Nutr. 130:1424S-1431S. https://www.ncbi.nlm.nih.gov/pubmed/10801955.

Shankar AH, Prasad AS. (1998) Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 68:447S-463S. https://www.ncbi.nlm.nih.gov/pubmed/9701160.

5. Selenium:

Beck MA, Levander OA, Handy J. (2003) Selenium deficiency and viral infection. J Nutr. 133:1463S-1467S.https://www.ncbi.nlm.nih.gov/pubmed/12730444.

Hoffmann PR, Berry MJ. (2008) The influence of selenium on immune responses. Mol Nutr Food Res. 52:1273-1280.https://www.ncbi.nlm.nih.gov/pubmed/18384097.

Steinbrenner H, Al-Quraishy S, Dkhil MA et al. (2015) Dietary selenium in adjuvant therapy of viral and bacterial infections. Adv Nutr. 6:73-82. https://www.ncbi.nlm.nih.gov/pubmed/25593145.

6. Klenner FR. The treatment of poliomyelitis and other virus diseases with vitamin C. J South Med Surg 1949, 111:210-214. http://www.doctoryourself.com/klennerpaper.html.

7. Cathcart RF. The method of determining proper doses of vitamin C for treatment of diseases by titrating to bowel tolerance. Australian Nurses J 1980, 9(4):9-13. http://www.doctoryourself.com/titration.html

FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, Feb 10, 2020

VITAMIN C AND ITS APPLICATION TO THE TREATMENT OF nCoV CORONAVIRUS

How Vitamin C Reduces Severity and Deaths from Serious Viral Respiratory Diseases

by Andrew W. Saul, Editor

(OMNS February 10, 2020) Most deaths from coronavirus are caused by pneumonia. Vitamin C has been known, for over 80 years, to greatly benefit pneumonia patients.

In 1936 Gander and Niederberger found that vitamin C lowered fever and reduced pain in pneumonia patients. [1]

Also in 1936, Hochwald independently reported similar results. He gave 500 mg of vitamin C every ninety minutes. [2]

McCormick gave 1000 mg vitamin C intravenously, followed by 500 mg orally every hour. He repeated the injection at least once. On the fourth day, his patient felt so well that he voluntarily resumed work, with no adverse effects. [3]

In 1944 Slotkin and Fletcher reported on the prophylactic and therapeutic value of vitamin C in bronchopneumonia, lung abscess, and purulent bronchitis. “Vitamin C has greatly alleviated this condition and promptly restored normal pulmonary function.” [4]

Slotkin further reported that “Vitamin C has been used routinely by the general surgeons in the Millard Fillmore Hospital, Buffalo, as a prophylactic against pneumonia, with complete disappearance of this complication.” [5]

According to the US Centers for Disease Control, there are about 80,000 dead from annual influenzas, escalating to pneumonia, in the USA. Coronavirus is a very serious contagious disease. But contagion to a virus largely depends on the susceptibility of the host. It is well established that low vitamin C levels increase susceptibility to viruses. [6]

Vitamin C lowers mortality

It is one thing to be sick from a virus and another thing entirely to die from a viral-instigated disease. It must be emphasized that a mere 200 mg of vitamin C/day resulted in an 80% decrease in deaths among severely ill, hospitalized respiratory disease patients. [7]

A single, cheap, big-box discount store vitamin C tablet will provide more than twice the amount used in the study above.

And yes, with vitamin C, more is better.

Frederick R. Klenner and Robert F. Cathcart successfully treated influenza and pneumonia with very high doses of vitamin C. Klenner published on his results beginning in the 1940s; [8] Cathcart beginning in the 1970s. [9] They used both oral and intravenous administration.

“Vitamin C is effective in reducing duration of severe pneumonia in children less than five years of age. Oxygen saturation was improved in less than one day.” [10]

A recent placebo controlled study concluded that “vitamin C should be included in treatment protocol of children with pneumonia so that mortality and morbidity can be reduced.” In this study, the majority of the children were infants under one year of age. By body weight, the modest 200 mg dose given, to tiny babies, would actually be the equivalent of 2,000-3,000 mg/day for an adult. [10]

Although many will rightly maintain that the dose should be high, even a low supplemental amount of vitamin C saves lives. This is very important for those with low incomes and few treatment options.

We’re talking about twenty cents’ worth of vitamin C a day to save lives now.

References:

1. Gander and Niederberger. Vitamin C in the handling of pneumonia.” Munch. Med. Wchnschr., 31: 2074, 1936.

2. Hochwald A. Beobachtungen uber Ascorbinsaurewirkung bei der krupposen Pneumonie.” Wien. Arch. f. inn. Med., 353, 1936.

3. McCormick WJ. Have we forgotten the lesson of scurvy? J Applied Nutrition, 1962, 15:1 & 2, 4-12.https://www.seleneriverpress.com/historical/have-we-forgotten-the-lesson-of-scurvy/

4. Slotkin & Fletcher. Ascorbic acid in pulmonary complications following prostatic surgery.” Jour. Urol., 52: Nov. 6, 1944.

5. Slotkin GE. Personal communication with WJ McCormick. December 2, 1946.

6. Saul AW. Nutritional treatment of coronavirus. Orthomolecular Medicine News Service, 16:6, Jan 30, 2020.http://orthomolecular.org/resources/omns/v16n06.shtml (22 references and 50 recommended papers for further reading)

7. Hunt C et al. The clinical effects of Vitamin C supplementation in elderly hospitalised patients with acute respiratory infections. Int J Vitam Nutr Res 1994;64:212-19. https://www.ncbi.nlm.nih.gov/pubmed/7814237

8. Klenner FR. Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology. J Applied Nutrition 1971, 23:3&4. http://www.doctoryourself.com/klennerpaper.html

Klenner FR. (1948) Virus pneumonia and its treatment with vitamin C. J South Med

Surg 110:36-8. https://www.seanet.com/~alexs/ascorbate/194x/klenner-fr-southern_med_surg-1948-v110-n2-p36.htm .

Klenner, FR. (1951) Massive doses of vitamin C and the virus diseases. J South Med and Surg, 113:101-107.

Klenner, FR. (1971) Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology. J. App. Nutr., 23:61-88.

All of Dr. Klenner’s papers are listed and summarized in: Clinical Guide to the Use of Vitamin C (ed. Lendon H. Smith, MD, Life Sciences Press, Tacoma, WA, 1988. This book is posted for free access athttp://www.seanet.com/~alexs/ascorbate/198x/smith-lh-clinical_guide_1988.htm

9. Cathcart RF. (1981) Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Med Hypotheses. 7:1359-76. http://www.doctoryourself.com/titration.html

Cathcart RF. (1993) The third face of vitamin C. J Orthomolecular Med, 7:197-200. Free access athttp://www.doctoryourself.com/cathcart_thirdface.html

Additional Dr. Cathcart papers are posted at http://www.doctoryourself.com/biblio_cathcart.html

10. Khan IM et al. (2014) Efficacy of vitamin C in reducing duration of severe pneumonia in children. J Rawalpindi Med Col (JRMC). 18(1):55-57. https://www.journalrmc.com/volumes/1405749894.pdf

Recommendations for further reading:

A coronavirus pandemic can be stopped with the immediate widespread use of high doses of vitamin C. Preventing and treating severe respiratory infections with large amounts of vitamin C is well established. There has been a lack of media coverage of this therapeutic approach against viruses in general, and coronavirus in particular. (A Chinese language edition is also freely available.)

The nutritional treatment of coronavirus is presented, with dosage specifics , in this protocol endorsed by physicians on the editorial board of the Orthomolecular Medicine News Service.

Exactly how to administer intravenous vitamin C to a hospitalized patient with a viral illness, by Atsuo Yanagisawa, MD, Japanese College of Intravenous Therapy. (Here is the IV vitamin C protocol in Chinese ).

Instructions on how to take high oral doses of vitamin C during illness, by Robert F. Cathcart III, MD. This paper contains the doctor’s answers to many questions about the therapeutic use of vitamin C.

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.

Editorial Review Board:

Ilyès Baghli, M.D. (Algeria) 
Ian Brighthope, M.D. (Australia) 
Richard Cheng, M.D., Ph.D. (USA) 
Prof. Gilbert Henri Crussol (Spain) 
Carolyn Dean, M.D., N.D. (USA) 
Damien Downing, M.D. (United Kingdom) 
Michael Ellis, M.D. (Australia) 
Martin P. Gallagher, M.D., D.C. (USA) 
Michael J. Gonzalez, N.M.D., D.Sc., Ph.D. (Puerto Rico) 
William B. Grant, Ph.D. (USA) 
Tonya S. Heyman, M.D. (USA) 
Suzanne Humphries, M.D. (USA) 
Ron Hunninghake, M.D. (USA) 
Michael Janson, M.D. (USA) 
Robert E. Jenkins, D.C. (USA) 
Bo H. Jonsson, M.D., Ph.D. (Sweden) 
Jeffrey J. Kotulski, D.O. (USA) 
Peter H. Lauda, M.D. (Austria) 
Thomas Levy, M.D., J.D. (USA) 
Homer Lim, M.D. (Philippines) 
Stuart Lindsey, Pharm.D. (USA) 
Victor A. Marcial-Vega, M.D. (Puerto Rico) 
Charles C. Mary, Jr., M.D. (USA) 
Mignonne Mary, M.D. (USA) 
Jun Matsuyama, M.D., Ph.D. (Japan) 
Dave McCarthy, M.D. (USA) 
Joseph Mercola, D.O. (USA) 
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico) 
Karin Munsterhjelm-Ahumada, M.D. (Finland) 
Tahar Naili, M.D. (Algeria) 
W. Todd Penberthy, Ph.D. (USA) 
Dag Viljen Poleszynski, Ph.D. (Norway) 
Jeffrey A. Ruterbusch, D.O. (USA) 
Gert E. Schuitemaker, Ph.D. (Netherlands) 
Thomas L. Taxman, M.D. (USA) 
Jagan Nathan Vamanan, M.D. (India) 
Garry Vickar, MD (USA) 
Ken Walker, M.D. (Canada) 
Anne Zauderer, D.C. (USA)

Andrew W. Saul, Ph.D. (USA), Editor-In-Chief 
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan) 
Robert G. Smith, Ph.D. (USA), Associate Editor 
Helen Saul Case, M.S. (USA), Assistant Editor 
Michael S. Stewart, B.Sc.C.S. (USA), Technology Editor

Jason M. Saul, JD (USA), Legal Consultant

Leave a Comment

Your email address will not be published. Required fields are marked *